$NN
NEXTNAV INC. Stock $nn

$nn Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024040871 Filed on May 08, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$1.105M	$1.046M	$1.205M
YoY Change	38.13%	26.02%	50.06%
Cost Of Revenue	$2.924M	$2.761M	$3.346M
YoY Change	-6.94%	-8.67%	13.89%
Gross Profit	-$1.819M	-$1.715M	-$2.141M
YoY Change	-22.33%	-21.8%	0.28%
Gross Profit Margin	-164.62%	-163.96%	-177.68%
Selling, General & Admin	$8.108M	$8.446M	$11.60M
YoY Change	24.43%	39.51%	64.52%
% of Gross Profit
Research & Development	$4.110M	$4.670M	$4.924M
YoY Change	-17.7%	2.01%	13.61%
% of Gross Profit
Depreciation & Amortization	$1.295M	$1.319M	$1.262M
YoY Change	9.93%	17.24%	24.46%
% of Gross Profit
Operating Expenses	$12.22M	$13.12M	$17.79M
YoY Change	-22.82%	-11.26%	43.45%
Operating Profit	-$15.33M	-$16.15M	-$19.93M
YoY Change	2.01%	15.77%	37.11%
Interest Expense	-$2.361M	-$2.208M	-$2.050M
YoY Change	588.34%	-570.79%	-549.56%
% of Operating Profit
Other Income/Expense, Net	$1.820M	-$72.00K	$5.645M
YoY Change	12900.0%	-11.11%	274.34%
Pretax Income	-$24.30M	-$31.60M	-$16.33M
YoY Change	55.77%	92.68%	29.93%
Income Tax	$68.00K	$44.00K	$62.00K
% Of Pretax Income
Net Earnings	-$24.39M	-$31.60M	-$16.40M
YoY Change	54.66%	93.87%	31.15%
Net Earnings / Revenue	-2207.24%	-3021.03%	-1360.66%
Basic Earnings Per Share	-$0.21	-$0.28
Diluted Earnings Per Share	-$0.21	-$0.28	-$0.15
COMMON SHARES
Basic Shares Outstanding	120.7M shares	111.2M shares	110.1M shares
Diluted Shares Outstanding	115.2K shares	111.1K shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$86.33M	$79.24M	$85.83M
YoY Change	1.54%	69.32%	54.8%
Cash & Equivalents	$62.97M	$73.32M	$81.88M
Short-Term Investments	$23.35M	$5.922M	$3.954M
Other Short-Term Assets	$15.59M	$16.05M	$3.056M
YoY Change	431.47%	341.62%	-14.54%
Inventory
Prepaid Expenses
Receivables	$2.248M	$1.496M	$2.332M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$104.2M	$96.79M	$91.22M
YoY Change	16.02%	87.49%	49.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$39.11M	$39.33M	$40.83M
YoY Change	-6.18%	11.61%	112.87%
Goodwill	$17.45M	$17.58M	$17.98M
YoY Change	-1.63%	-1.35%	2.77%
Intangibles	$10.14M	$10.36M	$10.63M
YoY Change
Long-Term Investments	$623.0K	$665.0K
YoY Change
Other Assets	$1.476M	$1.572M	$1.508M
YoY Change	-10.65%	-9.24%	-16.73%
Total Long-Term Assets	$68.17M	$68.84M	$70.94M
YoY Change	-4.91%	5.28%	13.32%
TOTAL ASSETS
Total Short-Term Assets	$104.2M	$96.79M	$91.22M
Total Long-Term Assets	$68.17M	$68.84M	$70.94M
Total Assets	$172.3M	$165.6M	$162.2M
YoY Change	6.73%	41.55%	31.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.145M	$1.269M	$391.0K
YoY Change	30.26%	93.45%	-61.63%
Accrued Expenses	$8.306M	$10.30M	$9.115M
YoY Change	-4.89%	38.57%	17.26%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.57M	$24.14M	$9.803M
YoY Change	81.6%	196.23%	10.31%
LONG-TERM LIABILITIES
Long-Term Debt	$51.40M	$49.89M	$48.45M
YoY Change	50.98%
Other Long-Term Liabilities	$1.584M	$1.596M	$23.81M
YoY Change	-3.83%	-0.25%	115.75%
Total Long-Term Liabilities	$52.98M	$51.49M	$72.26M
YoY Change	48.45%	3117.88%	554.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.57M	$24.14M	$9.803M
Total Long-Term Liabilities	$52.98M	$51.49M	$72.26M
Total Liabilities	$108.5M	$108.4M	$83.42M
YoY Change	63.41%	342.42%	318.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$816.2M	-$791.8M	-$760.2M
YoY Change	13.27%	12.34%	10.42%
Common Stock	$879.3M	$846.7M	$12.00K
YoY Change	8.55%	6.95%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$693.0K	$665.0K	$665.0K
YoY Change	17225.0%	16525.0%	16525.0%
Treasury Stock Shares
Shareholders Equity	$63.85M	$55.91M	$78.73M
YoY Change
Total Liabilities & Shareholders Equity	$172.3M	$165.6M	$162.2M
YoY Change	6.73%	41.55%	31.0%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$24.39M	-$31.60M	-$16.40M
YoY Change	54.66%	93.87%	31.15%
Depreciation, Depletion And Amortization	$1.295M	$1.319M	$1.262M
YoY Change	9.93%	17.24%	24.46%
Cash From Operating Activities	-$12.29M	-$7.000M	-$10.83M
YoY Change	44.77%	-5.41%	-9.04%
INVESTING ACTIVITIES
Capital Expenditures	$248.0K	$32.00K	$485.0K
YoY Change	-84.89%	-96.26%	-69.26%
Acquisitions
YoY Change
Other Investing Activities	-$19.96M	-$1.918M	$3.053M
YoY Change	-31.26%	-136.79%	-206.71%
Cash From Investing Activities	-$20.21M	-$2.113M	$2.568M
YoY Change	-34.13%	-152.61%	-157.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	22.16M	$516.0K	-21.00K
YoY Change	-53.98%	-51700.0%	2000.0%
NET CHANGE
Cash From Operating Activities	-12.29M	-$7.000M	-10.83M
Cash From Investing Activities	-20.21M	-$2.113M	2.568M
Cash From Financing Activities	22.16M	$516.0K	-21.00K
Net Change In Cash	-10.35M	-$8.561M	-8.286M
YoY Change	-215.2%	150.54%	-49.32%
FREE CASH FLOW
Cash From Operating Activities	-$12.29M	-$7.000M	-$10.83M
Capital Expenditures	$248.0K	$32.00K	$485.0K
Free Cash Flow	-$12.54M	-$7.032M	-$11.32M
YoY Change	23.77%	-14.83%	-16.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-31610000	usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001865631
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-40985
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	NextNav Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0854654
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1775 Tysons Blvd.
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	5th Floor
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	McLean
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	22102
CY2024Q1	dei	City Area Code CityAreaCode	800
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	775-0982
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	NN
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	120700334	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	73317000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81878000	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	5922000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	3954000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1496000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2332000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	16053000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3056000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	96788000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	91220000	usd
CY2024Q1	nn	Network Under Construction NetworkUnderConstruction	1693000	usd
CY2023Q4	nn	Network Under Construction NetworkUnderConstruction	1676000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10722000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9724000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	18890000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	19885000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18744000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19267000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	17581000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	17977000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10362000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10625000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1572000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1508000	usd
CY2024Q1	us-gaap	Assets Assets	165630000	usd
CY2023Q4	us-gaap	Assets Assets	162158000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1269000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	391000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	20161000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	6592000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2423000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2523000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	287000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	297000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	24140000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9803000	usd
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	17761000	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	7053000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14974000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	15145000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1596000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1614000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	49890000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	48447000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	108361000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	82062000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	112712136	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	111261434	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	112582924	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	111132222	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	12000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	12000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	846721000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	837416000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1676000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2198000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-791837000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-760227000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	129212	shares
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	129212	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	665000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	665000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	55907000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	78734000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	1362000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	1362000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	165630000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	162158000	usd
CY2024Q1	us-gaap	Revenues Revenues	1046000	usd
CY2023Q1	us-gaap	Revenues Revenues	830000	usd
CY2024Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	2761000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	3023000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4670000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4578000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8446000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6054000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1319000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1125000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	17196000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	14780000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16150000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-13950000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2168000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	469000	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	13176000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2800000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-72000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-81000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31566000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16362000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-13000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-16349000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-522000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	432000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32132000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15917000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-31610000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-16349000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-31610000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16349000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	111061	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	111061	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106405	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106405	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	80096000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	544000	usd
CY2024Q1	nn	Adjustments To Additional Paid In Capital Reclassification From Warrant Liability AdjustmentsToAdditionalPaidInCapitalReclassificationFromWarrantLiability	2468000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6293000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-31610000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-522000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	57269000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	103864000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	25000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4548000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-16349000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	92520000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-31610000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-16349000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1319000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1125000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4244000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3866000	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	13176000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2800000	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	50000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-16000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-40000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-55000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	16000	usd
CY2023Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	15000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1442000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-836000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-979000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	434000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	46000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	107000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-27000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	878000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-364000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-10000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-34000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	3022000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	395000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	253000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	88000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6985000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7427000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	856000	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	5918000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	4000000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	5213000	usd
CY2024Q1	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	163000	usd
CY2023Q1	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	341000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2113000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4016000	usd
CY2024Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	28000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	27000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	544000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	26000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	516000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8561000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3417000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81878000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47230000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73317000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43813000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	278000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	591000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-31600000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-16300000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7400000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	79200000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1046000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	830000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin: 0px; text-indent: 0px; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; line-height: inherit;">Use of Estimates</span></p> <p style="margin: 0pt; text-indent: 18pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> </span></p> <p style="margin: 0pt; text-align: justify; text-indent: 18pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period and accompanying notes. These estimates include those related to the useful lives and recoverability of long-lived and intangible assets, valuation of common stock warrants, income taxes and equity-based compensation, among others. NextNav bases estimates on historical experience, anticipated results and various other assumptions, including assumptions of future events, it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets, liabilities, equity, revenue and expenses, that are not readily apparent from other sources. Actual results and outcomes could differ materially from these estimates and assumptions. </span></p>
CY2024Q1	nn	Fair Value Option Changes In Fair Value Gain Loss On Available For Sale Debt Securities In Cash And Cash Equivalents FairValueOptionChangesInFairValueGainLossOnAvailableForSaleDebtSecuritiesInCashAndCashEquivalents	367000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2024Q1	us-gaap	Accounts Receivable Sale AccountsReceivableSale	1500000	usd
CY2023	us-gaap	Accounts Receivable Sale AccountsReceivableSale	2300000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	287000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	297000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4244000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3866000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-31610000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16349000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	111061	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	111061	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106405	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106405	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2024Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	17977000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	17493000	usd
CY2024Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-396000	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	328000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	17581000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	17821000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2881000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3913000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	828000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	324000	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	2333000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	583000	usd
CY2024Q1	nn	Asset Purchase Agreement Liability Current AssetPurchaseAgreementLiabilityCurrent	12284000	usd
CY2023Q4	nn	Asset Purchase Agreement Liability Current AssetPurchaseAgreementLiabilityCurrent		usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1835000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1772000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	20161000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	6592000	usd
CY2024Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	13967000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3605000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10362000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	13917000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3292000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10625000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	901000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1073000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	891000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	527000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3503000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6895000	usd
CY2024Q1	us-gaap	Other Receivables OtherReceivables	28000	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	107000	usd
CY2024Q1	us-gaap	Share Price SharePrice	6.58
CY2023Q4	us-gaap	Share Price SharePrice	4.45
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.5
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.5
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y6M29D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y9M25D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.855	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.669	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0448	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0405	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.61
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.91
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7053000	usd
CY2024Q1	nn	Fair Value Adjustment Of Private Placement Warrants FairValueAdjustmentOfPrivatePlacementWarrants	13176000	usd
CY2024Q1	nn	Adjustments To Additional Paid In Capital Reclassification From Warrant Liability AdjustmentsToAdditionalPaidInCapitalReclassificationFromWarrantLiability	2468000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	17761000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	44267686	shares
CY2024Q1	nn	Description Of Warrants DescriptionOfWarrants	the right to redeem the outstanding Public Warrants in whole and not in part at a price of $0.01 per warrant upon a minimum of 30 days’ prior written notice of redemption, if and only if the last sales price of the Company’s common stock matched or exceeded $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which NextNav sends the notice of redemption to the warrant holders.
CY2024Q1	nn	Capital Stock Shares Authorized CapitalStockSharesAuthorized	600000000	shares
CY2024Q1	nn	Capital Stock Par Or Stated Value Per Share CapitalStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	112712136	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	112582924	shares
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31600000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-13000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16400000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0008	pure

Files In Submission

Name	View Source	Status
0001213900-24-040871-index-headers.html	Edgar Link	pending
0001213900-24-040871-index.html	Edgar Link	pending
0001213900-24-040871.txt	Edgar Link	pending
0001213900-24-040871-xbrl.zip	Edgar Link	pending
ex101_1.htm	Edgar Link	pending
ex102_2.htm	Edgar Link	pending
ex103_3.htm	Edgar Link	pending
ex311_4.htm	Edgar Link	pending
ex312_5.htm	Edgar Link	pending
ex321_6.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nn-20240331.htm	Edgar Link	pending
nn-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
nn-20240331_cal.xml	Edgar Link	unprocessable
nn-20240331_def.xml	Edgar Link	unprocessable
nn-20240331_lab.xml	Edgar Link	unprocessable
nn-20240331_pre.xml	Edgar Link	unprocessable
nn-20240331_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NN
NEXTNAV INC. Stock $nn

2024 Q2 Form 10-Q Financial Statement

#000121390024040871 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NN NEXTNAV INC. Stock $nn

2024 Q2 Form 10-Q Financial Statement

#000121390024040871 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NN
NEXTNAV INC. Stock $nn